REFERENCE
GlaxoSmithKline.GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines. Media Release: 18 Feb 2010. Available from: URL: http://www.gsk.com
Rights and permissions
About this article
Cite this article
GSK responds to proposed LABA label revisions. React. Wkly. 1290, 3 (2010). https://doi.org/10.2165/00128415-201012900-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201012900-00008